LEMAITRE VASCULAR INC (LMAT) Stock Fundamental Analysis
NASDAQ:LMAT - Nasdaq - US5255582018 - Common Stock - Currency: USD
Overall LMAT gets a fundamental rating of 7 out of 10. We evaluated LMAT against 188 industry peers in the Health Care Equipment & Supplies industry. LMAT gets an excellent profitability rating and is at the same time showing great financial health properties. LMAT has a decent growth rate and is not valued too expensively. These ratings would make LMAT suitable for quality investing!
1. Profitability
1.1 Basic Checks
LMAT had positive earnings in the past year.
LMAT had a positive operating cash flow in the past year.
Each year in the past 5 years LMAT has been profitable.
In the past 5 years LMAT always reported a positive cash flow from operatings.
1.2 Ratios
LMAT's Return On Assets of 8.12% is amongst the best of the industry. LMAT outperforms 91.49% of its industry peers.
The Return On Equity of LMAT (12.99%) is better than 90.43% of its industry peers.
Looking at the Return On Invested Capital, with a value of 7.67%, LMAT belongs to the top of the industry, outperforming 87.23% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for LMAT is in line with the industry average of 7.71%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.12% | ||
| ROE | 12.99% | ||
| ROIC | 7.67% |
ROA(3y)7.77%
ROA(5y)8.17%
ROE(3y)10.28%
ROE(5y)10.74%
ROIC(3y)8.26%
ROIC(5y)8.93%
1.3 Margins
The Profit Margin of LMAT (19.96%) is better than 94.68% of its industry peers.
LMAT's Profit Margin has improved in the last couple of years.
LMAT's Operating Margin of 23.43% is amongst the best of the industry. LMAT outperforms 94.15% of its industry peers.
In the last couple of years the Operating Margin of LMAT has grown nicely.
With a decent Gross Margin value of 68.80%, LMAT is doing good in the industry, outperforming 77.66% of the companies in the same industry.
LMAT's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 23.43% | ||
| PM (TTM) | 19.96% | ||
| GM | 68.8% |
OM growth 3Y0.27%
OM growth 5Y5.61%
PM growth 3Y4.76%
PM growth 5Y5.57%
GM growth 3Y1.48%
GM growth 5Y0.13%
2. Health
2.1 Basic Checks
LMAT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, LMAT has more shares outstanding
LMAT has more shares outstanding than it did 5 years ago.
The debt/assets ratio for LMAT is higher compared to a year ago.
2.2 Solvency
LMAT has an Altman-Z score of 7.20. This indicates that LMAT is financially healthy and has little risk of bankruptcy at the moment.
LMAT has a Altman-Z score of 7.20. This is amongst the best in the industry. LMAT outperforms 86.70% of its industry peers.
LMAT has a debt to FCF ratio of 4.09. This is a neutral value as LMAT would need 4.09 years to pay back of all of its debts.
LMAT's Debt to FCF ratio of 4.09 is amongst the best of the industry. LMAT outperforms 85.11% of its industry peers.
A Debt/Equity ratio of 0.48 indicates that LMAT is not too dependend on debt financing.
LMAT has a Debt to Equity ratio of 0.48. This is comparable to the rest of the industry: LMAT outperforms 43.09% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.48 | ||
| Debt/FCF | 4.09 | ||
| Altman-Z | 7.2 |
ROIC/WACC0.86
WACC8.88%
2.3 Liquidity
A Current Ratio of 16.49 indicates that LMAT has no problem at all paying its short term obligations.
The Current ratio of LMAT (16.49) is better than 97.87% of its industry peers.
A Quick Ratio of 13.83 indicates that LMAT has no problem at all paying its short term obligations.
The Quick ratio of LMAT (13.83) is better than 96.81% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 16.49 | ||
| Quick Ratio | 13.83 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 31.13% over the past year.
LMAT shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 17.13% yearly.
LMAT shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 13.19%.
LMAT shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.41% yearly.
EPS 1Y (TTM)31.13%
EPS 3Y15.47%
EPS 5Y17.13%
EPS Q2Q%9.09%
Revenue 1Y (TTM)13.19%
Revenue growth 3Y12.5%
Revenue growth 5Y13.41%
Sales Q2Q%11.95%
3.2 Future
LMAT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.98% yearly.
The Revenue is expected to grow by 8.51% on average over the next years. This is quite good.
EPS Next Y13.94%
EPS Next 2Y12.52%
EPS Next 3Y11.58%
EPS Next 5Y9.98%
Revenue Next Year11.22%
Revenue Next 2Y10.01%
Revenue Next 3Y10.14%
Revenue Next 5Y8.51%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 40.94, LMAT can be considered very expensive at the moment.
LMAT's Price/Earnings ratio is a bit cheaper when compared to the industry. LMAT is cheaper than 70.21% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.19, LMAT is valued quite expensively.
With a Price/Forward Earnings ratio of 33.00, LMAT can be considered very expensive at the moment.
68.62% of the companies in the same industry are more expensive than LMAT, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of LMAT to the average of the S&P500 Index (22.13), we can say LMAT is valued slightly more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 40.94 | ||
| Fwd PE | 33 |
4.2 Price Multiples
73.40% of the companies in the same industry are more expensive than LMAT, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of LMAT indicates a somewhat cheap valuation: LMAT is cheaper than 74.47% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 44.54 | ||
| EV/EBITDA | 22.59 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
LMAT has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)2.94
PEG (5Y)2.39
EPS Next 2Y12.52%
EPS Next 3Y11.58%
5. Dividend
5.1 Amount
LMAT has a yearly dividend return of 0.98%, which is pretty low.
LMAT's Dividend Yield is rather good when compared to the industry average which is at 1.86. LMAT pays more dividend than 93.09% of the companies in the same industry.
With a Dividend Yield of 0.98, LMAT pays less dividend than the S&P500 average, which is at 2.40.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.98% |
5.2 History
On average, the dividend of LMAT grows each year by 13.60%, which is quite nice.
LMAT has been paying a dividend for at least 10 years, so it has a reliable track record.
LMAT has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)13.6%
Div Incr Years13
Div Non Decr Years13
5.3 Sustainability
LMAT pays out 33.89% of its income as dividend. This is a sustainable payout ratio.
LMAT's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP33.89%
EPS Next 2Y12.52%
EPS Next 3Y11.58%
81.07
+0.06 (+0.07%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners96.19%
Inst Owner Change0.58%
Ins Owners8.87%
Ins Owner Change-2.82%
Market Cap1.83B
Analysts76.47
Price Target106.59 (31.48%)
Short Float %6.26%
Short Ratio5.3
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.98% |
Yearly Dividend0.64
Dividend Growth(5Y)13.6%
DP33.89%
Div Incr Years13
Div Non Decr Years13
Ex-Date
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-4.01%
Min EPS beat(2)-5.52%
Max EPS beat(2)-2.5%
EPS beat(4)2
Avg EPS beat(4)2.64%
Min EPS beat(4)-5.52%
Max EPS beat(4)10.44%
EPS beat(8)6
Avg EPS beat(8)5.59%
EPS beat(12)7
Avg EPS beat(12)-0.64%
EPS beat(16)8
Avg EPS beat(16)-1.01%
Revenue beat(2)1
Avg Revenue beat(2)-0.28%
Min Revenue beat(2)-2.38%
Max Revenue beat(2)1.83%
Revenue beat(4)2
Avg Revenue beat(4)-0.13%
Min Revenue beat(4)-2.38%
Max Revenue beat(4)1.83%
Revenue beat(8)4
Avg Revenue beat(8)-0.14%
Revenue beat(12)5
Avg Revenue beat(12)-0.17%
Revenue beat(16)7
Avg Revenue beat(16)-0.34%
PT rev (1m)-1.07%
PT rev (3m)5.56%
EPS NQ rev (1m)-2.91%
EPS NQ rev (3m)0.01%
EPS NY rev (1m)-3.13%
EPS NY rev (3m)-0.08%
Revenue NQ rev (1m)2.23%
Revenue NQ rev (3m)1.31%
Revenue NY rev (1m)2.33%
Revenue NY rev (3m)1.49%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 40.94 | ||
| Fwd PE | 33 | ||
| P/S | 8.09 | ||
| P/FCF | 44.54 | ||
| P/OCF | 38.08 | ||
| P/B | 5.27 | ||
| P/tB | 7.41 | ||
| EV/EBITDA | 22.59 |
EPS(TTM)1.98
EY2.44%
EPS(NY)2.46
Fwd EY3.03%
FCF(TTM)1.82
FCFY2.25%
OCF(TTM)2.13
OCFY2.63%
SpS10.02
BVpS15.39
TBVpS10.94
PEG (NY)2.94
PEG (5Y)2.39
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.12% | ||
| ROE | 12.99% | ||
| ROCE | 9.98% | ||
| ROIC | 7.67% | ||
| ROICexc | 17.81% | ||
| ROICexgc | 31.73% | ||
| OM | 23.43% | ||
| PM (TTM) | 19.96% | ||
| GM | 68.8% | ||
| FCFM | 18.17% |
ROA(3y)7.77%
ROA(5y)8.17%
ROE(3y)10.28%
ROE(5y)10.74%
ROIC(3y)8.26%
ROIC(5y)8.93%
ROICexc(3y)14.32%
ROICexc(5y)13.54%
ROICexgc(3y)28.83%
ROICexgc(5y)29.82%
ROCE(3y)10.75%
ROCE(5y)11.62%
ROICexcg growth 3Y-0.4%
ROICexcg growth 5Y7.52%
ROICexc growth 3Y9.22%
ROICexc growth 5Y8.43%
OM growth 3Y0.27%
OM growth 5Y5.61%
PM growth 3Y4.76%
PM growth 5Y5.57%
GM growth 3Y1.48%
GM growth 5Y0.13%
F-Score5
Asset Turnover0.41
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.48 | ||
| Debt/FCF | 4.09 | ||
| Debt/EBITDA | 2.67 | ||
| Cap/Depr | 70.88% | ||
| Cap/Sales | 3.08% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 76.52% | ||
| Profit Quality | 91.04% | ||
| Current Ratio | 16.49 | ||
| Quick Ratio | 13.83 | ||
| Altman-Z | 7.2 |
F-Score5
WACC8.88%
ROIC/WACC0.86
Cap/Depr(3y)60.87%
Cap/Depr(5y)52.43%
Cap/Sales(3y)2.97%
Cap/Sales(5y)2.88%
Profit Quality(3y)96.62%
Profit Quality(5y)110.46%
High Growth Momentum
Growth
EPS 1Y (TTM)31.13%
EPS 3Y15.47%
EPS 5Y17.13%
EPS Q2Q%9.09%
EPS Next Y13.94%
EPS Next 2Y12.52%
EPS Next 3Y11.58%
EPS Next 5Y9.98%
Revenue 1Y (TTM)13.19%
Revenue growth 3Y12.5%
Revenue growth 5Y13.41%
Sales Q2Q%11.95%
Revenue Next Year11.22%
Revenue Next 2Y10.01%
Revenue Next 3Y10.14%
Revenue Next 5Y8.51%
EBIT growth 1Y29.64%
EBIT growth 3Y12.81%
EBIT growth 5Y19.77%
EBIT Next Year37.67%
EBIT Next 3Y21.1%
EBIT Next 5YN/A
FCF growth 1Y126.79%
FCF growth 3Y7.14%
FCF growth 5Y28.96%
OCF growth 1Y109.55%
OCF growth 3Y7.93%
OCF growth 5Y25.49%